Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries
Saved in:
Main Author: | Hyosun Kim (Author) |
---|---|
Format: | Book |
Published: |
Kerman University of Medical Sciences,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters
by: Hyosun Kim
Published: (2015) -
The Tip of the Iceberg of Misleading Online Advertising; Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"
by: Barbara Mintzes
Published: (2016) -
The Conundrum of Online Prescription Drug Promotion Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"
by: Isaac Wanasika
Published: (2016) -
Considering the Future of Pharmaceutical Promotions in Social Media; Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"
by: Francesca Renee Dillman Carpentier
Published: (2016) -
Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better?; Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"
by: Evan Doran
Published: (2016)